European equities traded in the US as American depositary receipts started the week modestly higher late Monday morning, rising 0.40% to 1,829.22 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Cellectis (CLLS) and medical device maker EDAP TMS (EDAP), which advanced 6.2% and 5% respectively. They were followed pharmaceutical company Novo Nordisk (NVO) and software firm SAP (SAP), which increased 4.1% and 2% respectively.

The decliners from continental Europe were led by semiconductor company Sequans Communications (SQNS) and consumer goods company Unilever (UL), which dropped 3.2% and 1.3% respectively. They were followed by internet advertising firm Criteo (CRTO) and health care tech company Royal Philips (PHG), which lost 0.7% and 0.2% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Biodexa Pharmaceuticals (BDRX) and Akari Therapeutics (AKTX), which rose 4.9% and 2.1% respectively. They were followed by oil and gas company Shell (SHEL) and mining company BHP Group (BHP), which were up 2% each.

The decliners from the UK and Ireland were led by biopharmaceutical company Mereo BioPharma Group (MREO) and pharmaceutical company Silence Therapeutics (SLN), which shed 9.3% and 6.7% respectively. They were followed by lender Lloyds Banking Group (LYG) and software company Endava (DAVA), which were down 3.7% and 3.1% respectively.